AMAC医药制造指数上涨1.01%,前十大权重包含云南白药等

金融界
23 Jun

金融界6月23日消息,上证指数低开高走,AMAC医药制造指数 (AMAC医药,H30054)上涨1.01%,报4295.51点,成交额556.83亿元。

数据统计显示,AMAC医药制造指数近一个月上涨1.76%,近三个月上涨6.11%,年至今上涨7.72%。

据了解,中基协基金估值行业分类指数依据《中国上市公司协会上市公司行业统计分类指引》中的门类划分,编制16个门类指数(不包括制造业);依据制造业门类下的大类划分,编制27个大类指数,共有43条行业分类指数。该指数以2009年01月01日为基日,以1000.0点为基点。

从指数持仓来看,AMAC医药制造指数十大权重分别为:恒瑞医药(10.8%)、片仔癀(2.79%)、云南白药(2.29%)、科伦药业(1.8%)、上海莱士(1.69%)、新和成(1.54%)、长春高新(1.5%)、常山药业(1.48%)、复星医药(1.46%)、百济神州(1.34%)。

从AMAC医药制造指数持仓的市场板块来看,上海证券交易所占比52.58%、深圳证券交易所占比47.42%。

从AMAC医药制造指数持仓样本的行业来看,医药卫生占比97.99%、主要消费占比1.94%、工业占比0.07%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10